{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:35:17Z","timestamp":1791275717811,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Cell Biol"],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p>T\u2010cell activation is considered to be an important element in the pathogenesis of psoriasis, a human skin disease characterized by keratinocyte hyperproliferation, altered keratinocyte differentiation and inflammation of the dermis and epidermis. Mice homozygous for the flaky skin (<jats:italic>fsn<\/jats:italic>) mutation develop a skin disorder that has histopathological and biochemical features resembling some forms of psoriasis. It has been reported recently that peripheral lymph nodes (PLN) in <jats:italic>fsn\/fsn<\/jats:italic> mice exhibit various abnormalities in T\u2010cell development suggestive of dysregulated T\u2010 and B\u2010cell activation. In the present study, the expression of the inducible T\u2010cell activation antigens CD69 and IL\u20102 receptor \u03b1 chain (CD25) on PLN cells from <jats:italic>fsn\/fsn<\/jats:italic> mice and their phenotypically normal littermates is examined. Expression of CD69 was significantly increased on PLN cells in <jats:italic>fsn\/fsn<\/jats:italic> mice (mean \u00b1 SD, 49.9 \u00b1 14.7% of cells) compared with control mice (14.6 \u00b1 4.2 %). Analysis of CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cell subsets revealed that expression of CD69 in <jats:italic>fsn\/fsn<\/jats:italic> PLN was significantly biased toward CD8<jats:sup>+<\/jats:sup> cells. Although expression of CD25 was preferentially associated with CD4<jats:sup>+<\/jats:sup> rather than CD8<jats:sup>+<\/jats:sup> cells in both <jats:italic>fsn\/fsn<\/jats:italic> and control PLN, with most CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup> cells being CD25<jats:sup>hi<\/jats:sup>, the proportion of CD4<jats:sup>+<\/jats:sup> cells expressing CD25 was higher in <jats:italic>fsn\/fsn<\/jats:italic> than control PLN. In contrast, CD25 was expressed by 2\u20133 % of CD8<jats:sup>+<\/jats:sup> PLN cells in both <jats:italic>fsn\/fsn<\/jats:italic> and control mice and CD25<jats:sup>hi<\/jats:sup> cells accounted for &lt; 1 % of CD8<jats:sup>+<\/jats:sup> cells in <jats:italic>fsn\/fsn<\/jats:italic> PLN. The paucity of CD25 on CD8<jats:sup>+<\/jats:sup> cells in <jats:italic>fsn\/fsn<\/jats:italic> PLN did not appear to be due to a defect in the ability of these cells to upregulate CD25, because T cell receptor stimulation <jats:italic>in vitro<\/jats:italic> induced high expression of CD25 on both CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> cells. A striking and consistent finding was that most CD8<jats:sup>+<\/jats:sup> cells in <jats:italic>fsn\/fsn<\/jats:italic> PLN expressed high levels of IL\u20102R \u03b2 chain (CD122). In contrast, CD122 was expressed at low levels on CD8<jats:sup>+<\/jats:sup> cells in control mice. Analysis of PLN cells from newborn <jats:italic>fsn\/fsn<\/jats:italic> mice revealed that the high expression of CD122 on CD8<jats:sup>+<\/jats:sup> cells was established by 2 weeks of age, prior to the appearance of clinical skin disease. These data indicate that large numbers of T cells in <jats:italic>fsn\/fsn<\/jats:italic> mice are activated and reinforce the view that <jats:italic>fsn<\/jats:italic> is an important regulator of lymphocyte development and function. The relationship between T\u2010cell activation and flaky skin disease in these mice remains to be established.<\/jats:p>","DOI":"10.1046\/j.1440-1711.2000.00945.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:42:28Z","timestamp":1047429748000},"page":"596-602","source":"Crossref","is-referenced-by-count":9,"title":["Dysregulated expression of CD69 and IL\u20102 receptor \u03b1 and \u03b2 chains on CD8<sup>+<\/sup> T lymphocytes in flaky skin mice"],"prefix":"10.1111","volume":"78","author":[{"given":"Nevin J","family":"Abernethy","sequence":"first","affiliation":[{"name":"Genesis Research and Development Corporation Limited  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hagan","sequence":"additional","affiliation":[{"name":"Haematology Department, Christchurch School of Medicine  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul LJ","family":"Tan","sequence":"additional","affiliation":[{"name":"Genesis Research and Development Corporation Limited  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Watson","sequence":"additional","affiliation":[{"name":"Genesis Research and Development Corporation Limited  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2000,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1038\/jid.1995.18","article-title":"Intralesional T\u2010lymphocyte activation as a mediator of psoriatic epidermal hyperplasia","volume":"105","author":"Bata\u2010Csorgo Z","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12276285"},{"key":"e_1_2_7_4_1","first-page":"580","article-title":"Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model","volume":"146","author":"Nickoloff BJ","year":"1995","journal-title":"Am. J. Pathol."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-183"},{"key":"e_1_2_7_6_1","first-page":"253","volume-title":"Handbook of Mouse Mutations with Skin and Hair Abnormalities","author":"Sundberg JP","year":"1994"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/08820139309063417"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12377741"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12512256"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12347791"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285389"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood.V86.8.3220.3220","article-title":"The flaky skin (fsn) mutation in mice: Map location and description of the anemia","volume":"86","author":"Beamer WG","year":"1995","journal-title":"Blood"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2000.00866.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1379::AID-IMMU1379>3.0.CO;2-3"},{"key":"e_1_2_7_15_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4049\/jimmunol.141.2.369","article-title":"Characterisation of a cell surface\u2010expressed disulfide\u2010linked dimer involved in murine T cell activation","volume":"141","author":"Yokoyama WM","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.3.1228"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90152-G"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.001333"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830251102"},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.147.7.2222","article-title":"A novel monoclonal antibody against murine IL\u20102 receptor \u03b2\u2010chain. Characterisation of receptor expression in normal lymphoid cells and EL\u20104 cells","volume":"147","author":"Tanaka T","year":"1991","journal-title":"J. Immunol."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240914"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1995.tb03412.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.168.5.1621","article-title":"Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes","volume":"168","author":"Cebrian M","year":"1998","journal-title":"J. Exp. Med."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06576.x"}],"container-title":["Immunology &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1711.2000.00945.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1711.2000.00945.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T06:03:52Z","timestamp":1695967432000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1711.2000.00945.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["10.1046\/j.1440-1711.2000.00945.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1711.2000.00945.x","archive":["Portico"],"relation":{},"ISSN":["0818-9641","1440-1711"],"issn-type":[{"value":"0818-9641","type":"print"},{"value":"1440-1711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}